| FRIDAY, MARCH 20, 2026 | ||
 | ||
| Bayer Industry Sponsored Luncheon Symposium (Lunch boxes served 12:30-12:45) | ||
| 12:45-13:45 | Confidence in practice: from evidence to experience | HALL A |
| 12:45-12:48 | Welcome and introductions Chair: Prof. Anat Loewenstein, Israel | |
| 12:48-12:58 | Expanding horizons: the latest updates with aflibercept 8mg Speaker: Prof. Marco Lupidi, Italy Panel: Assoc. Prof. Lasse Cehofski, Denmark; Prof. Paolo Lanzetta, Italy; Prof. Marco Lupidi, Italy; Prof. Sobha Sivaprasad , UK Moderator: Prof. Anat Loewenstein, Israel | |
| 12:58-13:20 | Shaping clinical practice: a flexible approach in nAMD and DME Speakers: Prof. Sobha Sivaprasad, UK ; Prof. Anat Loewenstein, Israel; Prof. Paolo Lanzetta, Italy ; Prof. Marco Lupidi, Italy Moderator: Prof. Anat Loewenstein, Israel | |
| 13:20-13:27 | Embracing the future: the next chapter in retinal care Speaker: Prof. Paolo Lanzetta, Italy | |
| 13:27-13:42 | Translating data into decisions: clinical controversies Panel: Assoc. Prof. Lasse Cehofski, Denmark; Prof. Paolo Lanzetta, Italy ; Prof. Marco Lupidi, Italy ; Prof. Sobha Sivaprasad, UK Moderator: Prof. Anat Loewenstein, Israel | |
| 13:42-13:45 | Summary and close Chair: Prof. Anat Loewenstein, Israel | |
 | ||
| AbbVie Industry Sponsored Dessert Symposium (Dessert served 13:45-14:00) | ||
| 14:00-15:00 | ||
| Round Table Debates Chair & Moderator: Slawomir Teper, Poland | ||
| 14:00-14:20 | Can inflammatory patient phenotypes transform DME treatment strategies? Discussion led by: Marco Lupidi, Italy | |
| 14:20-14:40 | Is there a window of opportunity to prevent irreversible vision loss in DME? Discussion led by: Marco Lupidi, Italy | |
| 14:40-15:00 | Can a corticosteroid provide rapid and sustained fluid resolution to intercept retinal damage and preserve long-term vision? Discussion led by Sara Touhami, France | |
| SATURDAY, MARCH 21, 2026 | ||
 | ||
| EssilorLuxottica Industry Sponsored Mini Symposium | ||
| 09:30-10:00 | Myopia Management Continuum Across the Lifespan: Optical and Pharmacological Interventions for Myopia Control, and Surgical Strategies | HALL A |
| 09:30-09:35 | Moderator: Olga Prenat, France | |
| 09:35-09:50 | Speaker: Andrzej Grzybowski, Poland | |
| 09:50-10:00 | Speaker: Alain Saad, France | |
| 12:05-12:50 | Industry Sponsored Innovation Symposium | HALL A |
| 12:05-12:20 | Building on a legacy of preserving and protecting vision through collaborations Horia Ijacu MD, MBA, International TA Head Eye Care and Specialty | |
| 12:20-12:35 | New Insights in Intravitreal Steroids in the DME Treatment Pathway Sobha Sivaprasad, UK |  |
| 12:35-12:50 | What’s New in Myopia Management? Olga Prenat, Global Head of Medical and Professional Affairs, EssilorLuxottica | |
 | ||
| Adverum Industry Sponsored Luncheon Symposium (Lunch boxes served 12:50-13:05 | ||
| 13:05-14:05 | Gene Therapy for Neovascular AMD: Employing Ocular Cells as Therapeutic Biofactories | |
| 14:20-15:05 | “On the Horizon” Industry Sponsored Dessert Symposium (Dessert served 14:05-14:20) | HALL A |
| 14:20-14:35 | Visionary Innovation in Ophthalmology Riad Sherif, Switzerland |  |
| 14:35-14:50 | Gene therapy for unmet needs in retinal disease Ram Palanki , USA |  |
| 14:50-15:05 | Exploring New Horizons in Retina: EYP-1901 and the Path to Durable Outcomes for Patients Anat Loewenstein, Israel |  |